The Utility of Biomarkers in Osteoporosis Management

Biochemical bone turnover markers in diabetes mellitus — A systematic review

(2016) Jakob Starup-Linde et al.   BONE

Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population

(2016) Zhaoli Dai et al.   BONE

Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis

(2016) Giovanni Adami et al.   CALCIFIED TISSUE INTERNATIONAL

Sclerostin Inhibition in the Management of Osteoporosis

(2016) Natasha M. Appelman-Dijkstra et al.   CALCIFIED TISSUE INTERNATIONAL

Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis

(2016) Marcello Rattazzi et al.   Cardiovascular Therapeutics

Decreased Cathepsin K Plasma Level may Reflect an Association of Osteopoenia/Osteoporosis with Coronary Atherosclerosis and Coronary Artery Calcification in Male Patients with Stable Angina

(2016) Olga L. Barbarash et al.   Heart Lung and Circulation

Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4

(2016) Wei Lv et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro

(2016) Ursula Heilmeier et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures

(2016) Roland Kocijan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating microRNAs as novel biomarkers for bone diseases – Complex signatures for multifactorial diseases?

(2016) Matthias Hackl et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Periostin action in bone

(2016) Nicolas Bonnet et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study

(2016) S. J. Bae et al.   OSTEOPOROSIS INTERNATIONAL

Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation

(2015) Sylvia Weilner et al.   BONE

Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site

(2015) Beom-Jun Kim et al.   BONE

Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis

(2015) Maurizio Rossini et al.   CALCIFIED TISSUE INTERNATIONAL

Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture

(2015) Layla Panach et al.   CALCIFIED TISSUE INTERNATIONAL

Role of biochemical markers in the management of osteoporosis

(2015) K. Henriksen et al.   CLIMACTERIC

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

(2015) Robert R. Recker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Reference Intervals for Bone Turnover Markers and Their Association With Incident Hip Fractures in Older Men: The Health In Men Study

(2015) S. A. Paul Chubb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients

(2015) P. Evenepoel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure

(2015) N. Bonnet et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study

(2015) J.C. Rousseau et al.   OSTEOARTHRITIS AND CARTILAGE

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study

(2015) K. E. Naylor et al.   OSTEOPOROSIS INTERNATIONAL

Understanding the local actions of lipids in bone physiology

(2015) Alexandrine During et al.   PROGRESS IN LIPID RESEARCH

The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient

(2015) B.-J. Kim et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis

(2015) Jia Meng et al.   PeerJ

Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients

(2014) Hongqiu Li et al.   BIOMARKERS

Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study

(2014) T.E. Finnes et al.   BONE

Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis

(2014) Davide Gatti et al.   BONE

A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture

(2014) Helena Johansson et al.   CALCIFIED TISSUE INTERNATIONAL

Five Freely Circulating miRNAs and Bone Tissue miRNAs Are Associated With Osteoporotic Fractures

(2014) Claudine Seeliger et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study

(2014) J. C. Rousseau et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis

(2014) J. Paccou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort

(2014) Noriko Yoshimura et al.   Modern Rheumatology

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

(2014) Michael R. McClung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of two commercially available ELISAs for circulating sclerostin

(2014) A. G. Costa et al.   OSTEOPOROSIS INTERNATIONAL

PINP as a biological response marker during teriparatide treatment for osteoporosis

(2014) J. H. Krege et al.   OSTEOPOROSIS INTERNATIONAL

Biochemical markers of bone turnover – uses and limitations

(2014) Thinn Thinn Hlaing et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover

(2013) L. Gifre et al.   BONE

The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women

(2013) Geeta Hampson et al.   BONE

Reference intervals for serum concentrations of three bone turnover markers for men and women

(2013) J. Michelsen et al.   BONE

Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes

(2013) Mohammed-Salleh M. Ardawi et al.   BONE

Periostin and transforming growth factor β-induced protein (TGFβIp) are both expressed by osteoblasts and osteoclasts

(2013) Blandine Merle et al.   CELL BIOLOGY INTERNATIONAL

The development and characterization of an ELISA specifically detecting the active form of cathepsin K

(2013) S. Sun et al.   CLINICAL BIOCHEMISTRY

Cathepsin K Inhibitors: A Novel Target but Promising Approach in the Treatment of Osteoporosis

(2013) Asadul Helali et al.   CURRENT DRUG TARGETS

Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels

(2013) S. Morales-Santana et al.   DIABETES CARE

Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: The Osteoporotic Fractures in Men (MrOS) study

(2013) Nancy E Lane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

MiR-503 Regulates Osteoclastogenesis via Targeting RANK

(2013) Chao Chen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Single- and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women

(2013) Juliet McColm et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial

(2013) Athanasios D. Anastasilakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women

(2013) Claire Durosier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus

(2013) Masahiro Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Assessment ofOPG/RANK/RANKLGene Expression Levels in Peripheral Blood Mononuclear Cells (PBMC) After Treatment With Strontium Ranelate and Ibandronate in Patients With Postmenopausal Osteoporosis

(2013) Michał Stuss et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Renal Elimination of Sclerostin Increases With Declining Kidney Function

(2013) Daniel Cejka et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

(2013) P. Farahmand et al.   OSTEOPOROSIS INTERNATIONAL

Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice

(2013) Nicolas Bonnet et al.   PLoS One

Mechanisms With Clinical Implications for Atrial Fibrillation–Associated Remodeling: Cathepsin K Expression, Regulation, and Therapeutic Target and Biomarker

(2013) Masaya Fujita et al.   Journal of the American Heart Association

MicroRNA Functions in Osteogenesis and Dysfunctions in Osteoporosis

(2013) Andre J. van Wijnen et al.   Current Osteoporosis Reports

Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis

(2012) Masaru Uchida et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Relationships Between Changes in Bone Mineral Density or Bone Turnover Markers and Vertebral Fracture Incidence in Patients Treated with Bazedoxifene

(2012) Olivier Bruyère et al.   CALCIFIED TISSUE INTERNATIONAL

Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness

(2012) S. Thambiah et al.   CALCIFIED TISSUE INTERNATIONAL

The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis

(2012) Pawel Szulc   CLINICAL BIOCHEMISTRY

Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab

(2012) Davide Gatti et al.   JOURNAL OF BONE AND MINERAL RESEARCH

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study

(2012) Mohammed-Salleh M Ardawi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

(2012) Richard M Jacques et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocyte RANKL: New insights into the control of bone remodeling

(2012) Jinhu Xiong et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study

(2012) Pawel Szulc et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Changes of Serum Soluble Receptor Activator for Nuclear Factor-κB Ligand after Glucocorticoid Therapy Reflect Regulation of Its Expression by Osteoblasts

(2012) Kaichi Kaneko et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Sphingosine 1-Phosphate Levels and the Risk of Vertebral Fracture in Postmenopausal Women

(2012) Beom-Jun Kim et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans

(2012) Seung Hun Lee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women

(2012) Aarthi Arasu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial

(2012) David W. Dempster et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes

(2012) Luigi Gennari et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Periostin promotes chronic allergic inflammation in response to Th2 cytokines

(2012) Miho Masuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Biomarkers for Osteoporosis Management

(2012) Patrick Garnero   Molecular Diagnosis & Therapy

miR-214 targets ATF4 to inhibit bone formation

(2012) Xiaogang Wang et al.   NATURE MEDICINE

MicroRNA control of bone formation and homeostasis

(2012) Jane B. Lian et al.   Nature Reviews Endocrinology

The role of FGF23 in CKD—with or without Klotho

(2012) Hirotaka Komaba et al.   Nature Reviews Nephrology

Bone turnover markers: use in osteoporosis

(2012) Kim Naylor et al.   Nature Reviews Rheumatology

The multiple facets of periostin in bone metabolism

(2012) B. Merle et al.   OSTEOPOROSIS INTERNATIONAL

Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study

(2012) P. Garnero et al.   OSTEOPOROSIS INTERNATIONAL

FGF23 production by osteocytes

(2012) Lynda F. Bonewald et al.   PEDIATRIC NEPHROLOGY

MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis

(2012) Yang Wang et al.   PLoS One

Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin

(2012) N. Bonnet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

XenomiRs and miRNA homeostasis in health and disease

(2012) Kenneth W. Witwer   RNA Biology

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis

(2011) Gisela Ruiz Heiland et al.   ANNALS OF THE RHEUMATIC DISEASES

Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis

(2011) Florence Chopin et al.   JOINT BONE SPINE

Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis

(2011) Emmanuel Biver et al.   JOINT BONE SPINE

Determinants of serum sclerostin in healthy pre- and postmenopausal women

(2011) Mohammed-Salleh M Ardawi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

(2011) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1

(2011) Davide Gatti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus

(2011) Antonia García-Martín et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women

(2011) Daniela Adolf et al.   MATURITAS

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

(2011) Kasey C. Vickers et al.   NATURE CELL BIOLOGY

Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial

(2011) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Relationship between serum RANKL and RANKL in bone

(2011) D. M. Findlay et al.   OSTEOPOROSIS INTERNATIONAL

Expression and Rhythmic Modulation of Circulating MicroRNAs Targeting the Clock Gene Bmal1 in Mice

(2011) Vikram R. Shende et al.   PLoS One

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

(2011) Asiri R. Wijenayaka et al.   PLoS One

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

(2011) J. D. Arroyo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PINP as an aid for monitoring patients treated with teriparatide

(2010) Mika Tsujimoto et al.   BONE

The syndromic status of sclerosteosis and van Buchem disease

(2010) P. Beighton et al.   CLINICAL GENETICS

Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase

(2010) Takumi Maruhashi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

(2010) P. Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men

(2010) Majd AI Mirza et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

(2010) John A Eisman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

(2010) Ulrike I Mödder et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women

(2010) Faryal S. Mirza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo

(2010) Masaru Ishii et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density

(2010) Joseph S. Butler et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Export of microRNAs and microRNA-protective protein by mammalian cells

(2010) Kai Wang et al.   NUCLEIC ACIDS RESEARCH

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

(2010) S. Vasikaran et al.   OSTEOPOROSIS INTERNATIONAL

Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis

(2009) N Voorzanger-Rousselot et al.   ANNALS OF THE RHEUMATIC DISEASES

High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression

(2009) Pablo Román-García et al.   BONE

Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma

(2009) Nathalie Voorzanger-Rousselot et al.   BRITISH JOURNAL OF HAEMATOLOGY

The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis

(2009) Athanasios D. Anastasilakis et al.   CLINICAL ENDOCRINOLOGY

The Matricellular Protein Periostin Is Required forSostInhibition and the Anabolic Response to Mechanical Loading and Physical Activity

(2009) Nicolas Bonnet et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture

(2009) Isao Kii et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years

(2009) Kaisa K Ivaska et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study

(2009) Douglas C Bauer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin in Mineralized Matrices and van Buchem Disease

(2009) R.L. van Bezooijen et al.   JOURNAL OF DENTAL RESEARCH

Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate

(2009) Manuel Muñoz-Torres et al.   MATURITAS

Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women

(2009) Janez Prezelj et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis

(2009) Masaru Ishii et al.   NATURE

Establishing a reference range for bone turnover markers in young, healthy women

(2008) S.J. Glover et al.   BONE

Determinants of Bone Turnover Markers in Healthy Premenopausal Women

(2008) Silvano Adami et al.   CALCIFIED TISSUE INTERNATIONAL

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: Effect of TNFα antagonist therapy

(2008) Daniel Wendling et al.   JOINT BONE SPINE

Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function

(2008) Toshifumi Sugatani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

(2008) Hua Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States

(2008) Sarah J Glover et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts

(2008) T. Roelofsen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Serum MicroRNAs Are Promising Novel Biomarkers

(2008) Shlomit Gilad et al.   PLoS One

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA